Peptide nucleic acids (PNAs) have recently been proposed as useful reagents in experiments aimed at the control of gene expression. PNAs backbone consists of N-(2-aminoethyl)-glycine units linked by amide bonds; therefore, these molecules are achiral and neutral, and are extremely efficient in hybridizing with DNA and RNA, generating PNA-DNA and PNA-RNA hybrid molecules exhibiting high stability even at low and medium ionic strength. PNA-mediated effects on in vitro and ex vivo transcription are here reviewed. Enhancing or inhibitory activity of PNAs on gene transcription have been reported to be mainly due to a process which involves strand invasion of target DNA containing homopurine/homopyrimidine stretches with the generation of(PNA)(2)/DNA triplexes. On the contrary, few informations are available on the possible use of PNAs as "decoy" molecules able to interact with DNA-binding proteins, including transcription factors. In this paper we also reviewed results from our laboratory obtained studying the effects of DNA/DNA, DNA/PNA or PNA/PNA molecules mimicking the NF-kB binding sites of the human immunodeficiency type 1 virus (HIV-1) on long terminal repeat (LTR)-driven in vitro transcription. The results herein reported allow to suggest that PNA/PNA molecules and DNA/PNA hybrids are capable to inhibit transcription through different mechanisms of action. The effects of PNAs and PNA/PNA hybrids on transcription are mainly due to strand invasion of target gene sequences. On the contrary, the activity of DNA/PNA on in vitro gene transcription could be due to direct interaction with transcription factors. These results should encourage studies on modified PNAs in older to deter-mine whether PNAs could be designed, synthetized and tested to exhibit a sequence-specific "decoy" activity. For this point of view, chiral PNAs, PHONA (in which the peptide bond is replaced by a phosphonic acid ester bridge) and PNA-DNA chimeras should be considered as potential molecules able to display efficient sequence-specific interactions with target proteins.